AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • August 2nd, 2022 • Evolus, Inc. • Pharmaceutical preparations • California
This Amended and Restated Employment Agreement is between Evolus, Inc., a Delaware corporation (the “Company”), and Rui Avelar, an individual (“Employee”). This Agreement is entered into effective as of August 1, 2022 (the “Effective Date”). This Amended and Restated Employment Agreement amends and restates in its entirety that certain Employment Agreement dated as of August 15, 2018 by and between the Company and Employee (the “Original Agreement”).
FIRST AMENDMENT TO LOAN AGREEMENTLoan Agreement • August 2nd, 2022 • Evolus, Inc. • Pharmaceutical preparations • New York
This FIRST AMENDMENT TO LOAN AGREEMENT (this “Amendment”), dated and effective as of April 5, 2022 (the “Effective Date”), is made by and among EVOLUS, INC., a Delaware corporation (as “Borrower” and a Credit Party), BIOPHARMA CREDIT PLC, a public limited company incorporated under the laws of England and Wales with company number 10443190 (as the “Collateral Agent”), BPCR LIMITED PARTNERSHIP, a limited partnership established under the laws of England and Wales with registration number LP020944 (as a “Lender”) and BIOPHARMA CREDIT INVESTMENTS V (MASTER) LP, a Cayman Islands exempted limited partnership acting by its general partner, BioPharma Credit Investments V GP LLC (as a “Lender”).
AMENDMENT TO EMPLOYMENT AGREEMENTEmployment Agreement • August 2nd, 2022 • Evolus, Inc. • Pharmaceutical preparations • California
This Amendment to Employment Agreement (this “Amendment”) is between Evolus, Inc., a Delaware corporation (the “Company”), and David Moatazedi, an individual (“Employee”). This Amendment is entered into effective as of August 1, 2022 (the “Effective Date”).
